scholarly journals Macrophage migration inhibitory factor: An emerging therapeutic target in rheumatoid arthritis

2003 ◽  
Vol 48 (2) ◽  
pp. 291-299 ◽  
Author(s):  
Eric F. Morand ◽  
Richard Bucala ◽  
Michelle Leech
2021 ◽  
Vol 77 (3) ◽  
pp. 293-299
Author(s):  
Kei Fukushima ◽  
Minoru Furuya ◽  
Takashi Kamimura ◽  
Midori Takimoto-Kamimura

Methotrexate (MTX) is an anticancer and anti-rheumatoid arthritis drug that is considered to block nucleotide synthesis and the cell cycle mainly by inhibiting the activity of dihydrofolate reductase (DHFR). Using affinity-matrix technology and X-ray analysis, the present study shows that MTX also interacts with macrophage migration inhibitory factor (MIF). Fragment molecular-orbital calculations quantified the interaction between MTX and MIF based on the structure of the complex and revealed the amino acids that are effective in the interaction of MTX and MIF. It should be possible to design new small-molecule compounds that have strong inhibitory activity towards both MIF and DHFR by structure-based drug discovery.


2011 ◽  
Vol 32 (8) ◽  
pp. 2307-2311 ◽  
Author(s):  
Mara Anaís Llamas-Covarrubias ◽  
Yeminia Valle ◽  
Rosa Elena Navarro-Hernández ◽  
Iris Paola Guzmán-Guzmán ◽  
María Guadalupe Ramírez-Dueñas ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document